Skip to content
2000
Volume 16, Issue 9
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

It has been confirmed that apoptosis, autophagy and necrosis are the three major modes of cell death. For a long time, necrosis is regarded as a deranged or accidental cell demise. In recent years, there is evidence showing that necrotic cell death can be a well regulated and orchestrated event, which is also known as programmed cell death or "necroptosis". Necroptosis can be triggered by a variety of external stimuli and regulated by a caspase-independent pathway. It plays a key role in the pathogenesis of some diseases including neurological diseases. In the past two decades, a variety of studies have revealed that the necroptosis related pathway is activated in stroke, and plays a crucial role in the pathogenesis of stroke. Moreover, necroptosis may serve as a potential target in the therapy of stroke because genetic or pharmacological inhibition of necroptosis has been shown to be neuroprotective in stroke in vitro and in vivo. In this review, we briefly summarize recent advances in necroptosis, introduce the mechanism and strategies targeting necroptosis in stroke, and finally propose some issues in the treatment of stroke by targeting necroptosis.

Loading

Article metrics loading...

/content/journals/cn/10.2174/1570159X16666180416152243
2018-11-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/cn/10.2174/1570159X16666180416152243
Loading

  • Article Type:
    Review Article
Keyword(s): MLKL; Nec-1; necroptosis; Programmed cell death; RIP1; RIP3; stroke
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test